Northwind Pharmaceuticals recalled Sulfamethoxazole and Trimethoprim Tablets on August 20, 2025. The recall affects several lot numbers due to a foreign substance found in packaging. Consumers should stop using the product and seek guidance immediately.
Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Consumers and healthcare providers should stop using this product immediately. Contact Northwind Pharmaceuticals LLC or your healthcare provider for guidance. Notification method: Letter
The recall includes Sulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength. Affected packaging includes 6-count (NDC 51655-307-87), 10-count (NDC 51655-307-53), 14-count (NDC 51655-307-84), and 20-count bottles (NDC 51655-307-20). A total of 2,295 bottles are recalled.
The recall was initiated due to the detection of a micro-organism on a specific lot of auxiliary polyester coil used in product packaging. No micro-organism was detected on any of the tablets themselves.
There have been no reported injuries or incidents associated with the contaminated product. The presence of the micro-organism poses a high risk to consumer safety.
Consumers and healthcare providers should immediately stop using the recalled product. Contact Northwind Pharmaceuticals LLC or consult a healthcare provider for further guidance.
For more information, contact Northwind Pharmaceuticals at their official website or through the FDA recall link.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.